Resection Of Primary Malignant Tumors Research Articles

Liver resection versus ablation in geriatric populations - Does one method impart improved in-hospital mortality?

Objective: This study aimed to compare surgical resection versus ablation for managing liver malignancies in patients 65 and older. Material and Methods: Cases with liver tumors were extracted from the NSQIP database for patients aged ≥65 years. Following propensity score matching, multivariate Cox regression was used for 30-day morbidity and mortality for liver resection and ablation. Results: Following a propensity score matching, 1048 patients were 1:1 matched for comorbid conditions. Patients stayed in the hospital three days longer after resection (p<0.001). Mortality was lower after ablation (p= 0.013). This difference was more prominent in patients with primary liver tumors (p= 0.008). Group A had a 10-fold lower risk of developing an abdominal abscess, a fourfold decrease in hospital-associated pneumonia (p= 0.001) and reintubation, a 10-fold reduction in bleeding requiring transfusion (p<0.001), and a three-fold decrease in risk of developing sepsis (p<0.001). Conclusion: Despite being a generally sicker patient population with worse underlying liver function, ablative techniques were associated with a lower risk of adverse outcomes when compared to more aggressive resection of primary malignant tumors of the liver.

154. The use of autologous free vascularized fibula grafts in reconstruction of the mobile spine following tumor resection: illustrated surgical technique and outcomes

BACKGROUND CONTEXT Reconstruction of the mobile spine following total en bloc spondylectomy (TES) of one or multiple vertebral bodies in patients suffering from malignant spinal tumors is a challenging procedure with high failure rates. One of the most common reasons for reconstructive failure is nonunion, which is an even greater problem in the setting of local radiation. Radiation is an integral part of the management of primary malignant bone tumors in the spine at our institution. Vascularized grafts may help prevent nonunion in the setting of radiation therapy. We have routinely utilized free vascularized fibular grafts (FVFG) for the reconstruction of the mobile spine following TES. PURPOSE The purpose of this study is to describe the surgical technique utilized for vascularized reconstruction of defects following TES. In addition, we report the outcomes of a consecutive series of patients treated with this technique. STUDY DESIGN/SETTING Retrospective review of electronic health records at one tertiary care center and an illustrated explanation of the surgical technique. PATIENT SAMPLE Adult patients, 18 years or older, undergoing total en bloc resection of primary malignant tumors of the mobile spine followed by reconstruction using a free vascularized fibula graft. OUTCOME MEASURES The primary outcome was reconstruction failure of the construct. METHODS Thirty-nine patients treated at our tertiary care institution between 2010 and 2018 for a diagnosis of malignant tumor in the mobile spine with the use of FVFG following TES were reviewed. Postoperative union, complications, neurological outcome, reoperations, and survival were reported. The median time of follow-up was 50 months (range, 14 – 109 months). RESULTS The cohort consisted of 26 males and 13 females, with a median age of 58 years. Chordoma was the tumor that occurred most often (67%) and tumors occurred most often in the lumbar spine (46%). Complete union was seen in 26 patients (76%), the overall complication rate was 56%, and instrumentation failure was the most common complication with 26% of patients affected. In total 12 patients (31%) suffered from – instrumentation loosening or breakage, nonunion, graft fracture, or a combination of these – for which ten patients (26%) required revision surgery. The fixation was revised a total of 15 times (42% of reoperations). In 18 patients (46%) one or more reoperations were needed. The overall 1-, 3-, and 5-year survival rate was 95%, 92%, and 87%, respectively. CONCLUSIONS The FVFG is an adequate reconstruction technique of the mobile spine following TES for malignant tumors. Although we see higher union rates and comparable complication rates compared to other techniques, the rate of instrumentation failure was high. FDA DEVICE/DRUG STATUS This abstract does not discuss or include any applicable devices or drugs.

What is the Likelihood That Tumor Endoprostheses Will Experience a Second Complication After First Revision in Patients With Primary Malignant Bone Tumors And What Are Potential Risk Factors?

Endoprosthetic reconstruction of massive bone defects has become the reconstruction method of choice after limb-sparing resection of primary malignant tumors of the long bones. Given the improved survival rates of patients with extremity bone sarcomas, an increasing number of patients survive but have prosthetic complications over time. Several studies have reported on the outcome of first endoprosthetic complications. However, no comprehensive data, to our knowledge, are available on the likelihood of an additional complication and the associated risk factors, despite the impact of this issue on the affected patients. (1) What are the types and timing of complications and the implant survivorship free from revision after the first complication? (2) Does survivorship free from repeat revision for a second complication differ by anatomic sites? (3) Is the type of first complication associated with the risk or the type of a second complication? (4) Are patient-, tumor-, and treatment-related factors associated with a higher likelihood of repeat revision? Between 1993 and 2015, 817 patients underwent megaprosthetic reconstruction after resection of a tumor in the long bones with a single design of a megaprosthetic system. No other prosthetic system was used during the study period. Of those, 75% (616 of 817) had a bone sarcoma. Seventeen patients (3%) had a follow-up of less than 6 months, 4.5% (27 of 599) died with the implant intact before 6 months and 43% (260 of 599 patients) underwent revision. Forty-three percent of patients (260 of 599) experienced a first prosthetic complication during the follow-up period. Ten percent of patients (26 of 260) underwent amputation after the first complication and were excluded from further analysis. Second complications were classified using the classification of Henderson et al. to categorize surgical results. Briefly, this system categorizes complications as wound dehiscence (Type 1); aseptic loosening (Type 2); implant fractures or breakage and periprosthetic fracture (Type 3); infection (Type 4); and tumor progression (Type 5). Implant survival curves were calculated with the Kaplan-Meier method and compared using the log-rank test. Hazard ratios (HR) were estimated with their respective 95% CIs in multivariate Cox regression models. A second complication occurred in 49% of patients (115 of 234) after a median of 17 months (interquartile range [IQR] 5 to 48) after the surgery for the first complication. The time to complication did not differ between the first (median 16 months; IQR 5 to 57) and second complication (median 17 months; IQR 5 to 48; p = 0.976). The implant survivorship free from revision surgery for a second complication was 69% (95% CI 63 to 76) at 2 years and 46% (95% CI 38 to 53) at 5 years. The most common mode of second complication was infection 39% (45 of 115), followed by structural complications with 35% (40 of 115). Total bone and total knee reconstructions had a reduced survivorship free from revision surgery for a second complication at 5 years (HR 2.072 [95% CI 1.066 to 3.856]; p = 0.031) compared with single joint replacements. With the numbers we had, we could not show a difference between the survivorship free of revision for a second complication based on the type of the first complication (HR 0.74 [95% CI 0.215 to 2.546]; p = 0.535). We did not detect an association between total reconstruction length, patient BMI, and patient age and survivorship free from revision for a second complication. Patients had a higher risk of second complications after postoperative radiotherapy (HR 1.849 [95% CI 1.092 to 3.132]; p = 0.022) but not after preoperative radiotherapy (HR 1.174 [95% CI 0.505 to 2.728]; p = 0.709). Patients with diabetes at the time of initial surgery had a reduced survivorship free from revision for a second complication (HR 4.868 [95% CI 1.497 to 15.823]; p = 0.009). Patients who undergo revision to treat a first megaprosthetic complication must be counseled regarding the high risk of future complications. With second complications occurring relatively soon after the first revision, regular orthopaedic follow-up visits are advised. Preoperative rather than postoperative radiotherapy should be performed when possible. Future studies should evaluate the effectiveness of different approaches in treating complications considering implant survivorship free of revision for a second complication. Level III, therapeutic study.

Is the Induced-membrane Technique Successful for Limb Reconstruction After Resecting Large Bone Tumors in Children?

Resection of primary malignant tumors often creates large bony defects. In children, this creates reconstructive challenges, and many options have been described for limb salvage in this setting. Studies have supported the use of an induced-membrane technique after placement of a cement spacer to aid in restoration of bone anatomy. We asked: (1) What complications are associated with the induced-membrane technique? (2) How often is bone healing achieved after resection greater than 15 cm using this technique? (3) What is the functional outcome of patients treated with this technique? We performed a retrospective evaluation of eight patients with a mean age of 13.3 years (range, 11-17 years) treated for a malignant bone tumor between 2002 and 2012 at our centers. The primary malignant tumors involved the proximal humerus, femur, and tibia. All patients were treated using the induced-membrane technique after a resection with mean bone loss of 18 cm (range, 16-23 cm). The general indication for using the induced-membrane technique during this time was a large diaphyseal defect after resection of the tumor. In addition to using cancellous graft as with the original technique, in the current patients an autogenous nonvascularized fibula was used to enhance stability. The patients were assessed at the last followup using the Musculoskeletal Tumor Society (MSTS) scoring system. Mean followup was 47.1 months (range, 24-120 months), and none of the patients were lost to followup before 2 years. A total of four unplanned reoperations were performed in these eight patients. A fracture of the reconstruction occurred in three patients and all were treated successfully, two with surgery and one with immobilization. Bone fusion was obtained in all patients within 4 to 8 months (mean, 5.6 months) after the reconstruction. The mean healing index was 0.31 month/cm of reconstruction (range, 0.23-0.5 month/cm). At last followup, the mean MSTS score was 74% (range, 67%-80%). Our findings suggest that the modified induced-membrane technique is a reasonable alternative to other limb reconstruction techniques for bone tumors in children and has the advantage of not requiring a bone bank or an expensive metal prosthesis. Although more patients will be needed to substantiate our findings, it has become a standard part of our arsenal in the treatment of large bone defects after resection of pediatric primitive bone tumors. Level IV, therapeutic study.

[Surgical therapy of pelvis and spine in primary malignant bone tumors].

Despite standardization of surgical treatment of primary malignant tumors of the pelvis and spine, prognosis in these centrally located tumors still is inferior compared to those located in the extremities. This fact may be attributed to delayed diagnosis in many cases and the resulting increase in tumor volume as well as to difficulties of resection due to the anatomical situation. The frequency of local recurrence after resection of primary malignant tumors is reported to be between 4 and 41% and the 5-year survival rate below 40%. Whereas the latter has remained almost unchanged during the past 20 years, amputation has been replaced by limb-salvage surgery except for a minimal amount of less than 10%. For reconstruction, biological techniques are increasingly preferred to endoprosthetic replacement or use of bulk allografts because of the high complication rate. Even in the spine wide resections are feasible provided at least one lamina is healthy in order to prepare and save the neural structures without touching the tumor. Compared to the widely used technique of curettage, en bloc resection may provide a significantly better oncologic result with respect to local tumor control. Failure of the dorsoventral stabilization with delayed union is the most frequent complication of these challenging procedures. In order to improve the long-term prognosis of these groups of patients in the future, early diagnosis and immediate admission to a specialized tumor service has to be attempted.

Major Hepatic Resection: An Update

In 1981, we reported a series of 75 major hepatic resections done over a ten-year period; 58 were for hepatic trauma, nine were for benign disease, and eight were for malignant disease. Since that report, the indications for major hepatic resection have changed, with a more conservative approach to hepatic trauma and a more aggressive approach toward hepatic tumors. In this update, we report 88 hepatic resections from Vanderbilt University Hospital and Metropolitan Nashville General Hospital; 32 were for trauma, 25 were for benign disorders, and 31 were for malignant disease. Since 1977, nine adults and four children have had hepatic resection for primary malignant tumors; there were six hepatocellular lesions, three hepatoblastomas, two malignant hemangioendotheliomas, one malignant hepatoma, and one intrahepatic cholangiocarcinoma. At the time of this writing, the four children have survived for 7.3, 6, 6, and 3.8 years (mean 5.7), and all are alive without evidence of recurrence. For the nine adults, survival has averaged 1.7 years, excluding one postoperative death. Three adult patients are alive at this writing, one of whom is a five-year survivor without evidence of disease. Seventeen adults and one child had hepatic resection for metastatic lesions. In the adults, the primary tumor was in the colon in 14 cases and in the small bowel, stomach, and an unknown site in one case each. The one child had a metastatic Wilms' tumor. Survival has averaged two years, with two long-term survivors (nine years). Six patients are alive at this time. Operative mortality for elective resection has decreased from 12% (2/17) in our earlier report to 3% (1/31) in this series, which has encouraged us to assume a more aggressive approach to the resection of malignant primary and metastatic liver tumors.